Federal award
NOVA BIOMEDICAL CORP
W91YTZ19P0443
Contract
Obligated and Ceiling
- Obligated (net)
- $128,640.00
- Ceiling (potential value, not spending)
- $128,640.00
- Current value
- $128,640.00
- Gross positive obligations
- $189,900.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- NOVA BIOMEDICAL CORP · LCFDHTGXB5J3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- NOVA BIOMEDICAL CORP · LCFDHTGXB5J3
- Awarding agency
- Department of War · sub-agency 2100 · office W91YTZ
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W91YTZ19P0443
- Award type code
- B
- Actions
- 13 · Sep 27, 2019 to Apr 29, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History13
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 29, 2025 | FY2025 | P00012 | C | −$61,260.00 | — |
| Nov 14, 2023 | FY2024 | P00011 | C | $25,500.00 | — |
| Aug 16, 2023 | FY2023 | P00010 | G | $0.00 | — |
| Oct 19, 2022 | FY2023 | P00009 | C | $25,500.00 | — |
| Jul 11, 2022 | FY2022 | P00008 | G | $0.00 | — |
| Oct 12, 2021 | FY2022 | P00007 | C | $25,500.00 | — |
| Jul 26, 2021 | FY2021 | P00006 | G | $0.00 | — |
| Jun 16, 2021 | FY2021 | P00005 | B | $0.00 | — |
| Nov 17, 2020 | FY2021 | P00004 | C | $25,500.00 | — |
| Sep 30, 2020 | FY2020 | P00003 | G | $0.00 | — |
| Nov 6, 2019 | FY2020 | P00002 | C | $87,900.00 | — |
| Sep 27, 2019 | FY2019 | 0 | — | $0.00 | — |
| Sep 27, 2019 | FY2019 | P00001 | M | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.